82_FR_16280 82 FR 16218 - Center for Scientific Review; Notice of Closed Meetings

82 FR 16218 - Center for Scientific Review; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 62 (April 3, 2017)

Page Range16218-16219
FR Document2017-06402

Federal Register, Volume 82 Issue 62 (Monday, April 3, 2017) 
[Federal Register Volume 82, Number 62 (Monday, April 3, 2017)]
[Notices]
[Pages 16218-16219]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-06402]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Clinical Neuroimmunology and Brain Tumor SEP.
    Date: April 14, 2017.
    Time: 2:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Wei-Qin Zhao, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5181, MSC 7846, Bethesda, MD 20892-7846, 301-
827-7238, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: HIV and Related Research.
    Date: April 19, 2017.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Barna Dey, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3184, Bethesda, MD 20892, 301-451-2796, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Clinical Oncology.
    Date: April 25, 2017.
    Time: 1:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Nicholas J. Donato, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4040, Bethesda, MD 20817, 301-
827-4810, [email protected].


[[Page 16219]]


(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: March 28, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-06402 Filed 3-31-17; 8:45 am]
BILLING CODE 4140-01-P

16218 Federal Register / Vol. 82, No. 62 / Monday, April 3, 2017 / Notices of the oral presentation/statement must discuss submitted public comments, DEPARTMENT OF HEALTH AND be submitted by 5:00 p.m. ET on and foster discussions where HUMAN SERVICES Tuesday, April 18, 2017. A limited participants can comfortably offer number of slots for oral comment are opposing opinions.’’ In keeping with National Institutes of Health available, and in order to ensure that as this core value, the IACC and the NIMH many different individuals are able to Office of Autism Research Coordination Center for Scientific Review; Notice of present throughout the year as possible, (OARC) ask that members of the public Closed Meetings any given individual only will be who provide public comments or Pursuant to section 10(d) of the permitted to present oral comments participate in meetings of the IACC also Federal Advisory Committee Act, as once per calendar year (2017). Only one seek to treat others with respect and amended (5 U.S.C. App.), notice is representative of an organization will be consideration in their communications hereby given of the following meetings. allowed to present oral comments in and actions, even when discussing The meetings will be closed to the any given meeting; other representatives issues of genuine concern or public in accordance with the of the same group may provide written disagreement. provisions set forth in sections comments. If the oral comment session 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., is full, individuals who could not be Remote Access as amended. The grant applications and accommodated are welcome to provide The meeting will be open to the the discussions could disclose written comments instead. Comments to public through a conference call phone confidential trade secrets or commercial be read or presented in the meeting number and webcast live on the property such as patentable material, must not exceed 250 words or 3 Internet. Members of the public who and personal information concerning minutes, but a longer version may be participate using the conference call individuals associated with the grant submitted in writing for the record. phone number will be able to listen to applications, the disclosure of which Commenters going beyond the 250 word the meeting but will not be heard. If you would constitute a clearly unwarranted or 3 minute time limit in the meeting experience any technical problems with invasion of personal privacy. may be asked to conclude immediately the webcast or conference call, please in order to allow other comments and send an email to IACCPublicInquiries@ Name of Committee: Center for Scientific presentations to proceed on schedule. Review Special Emphasis Panel; Clinical mail.nih.gov. Neuroimmunology and Brain Tumor SEP. Any interested person may submit Individuals wishing to participate in Date: April 14, 2017. written public comments to the IACC person or by using these electronic Time: 2:00 p.m. to 3:00 p.m. prior to the meeting by emailing the services and who need special Agenda: To review and evaluate grant comments to IACCPublicInquiries@ assistance, such as captioning of the applications. mail.nih.gov or by submitting comments conference call or other reasonable Place: National Institutes of Health, 6701 at the web link: https://iacc.hhs.gov/ accommodations, should submit a Rockledge Drive, Bethesda, MD 20892 meetings/public-comments/submit/ request to the Contact Person listed on (Telephone Conference Call). index.jsp by 5:00 p.m. ET on Tuesday, this notice at least five days prior to the Contact Person: Wei-Qin Zhao, Ph.D., April 18, 2017. The comments should Scientific Review Officer, Center for meeting. include the name, address, telephone Scientific Review, National Institutes of number, and when applicable, the Security Health, 6701 Rockledge Drive, Room 5181, MSC 7846, Bethesda, MD 20892–7846, 301– business or professional affiliation of In the interest of security, NIH has 827–7238, zhaow@csr.nih.gov. the interested person. NIMH anticipates instituted stringent procedures for Name of Committee: Center for Scientific written public comments received by entrance onto the NIH campus. All Review Special Emphasis Panel; Member 5:00 p.m. ET on Tuesday, April 18, 2017 visitor vehicles, including taxicabs and Conflict: HIV and Related Research. will be presented to the Committee prior hotel and airport shuttles, will be Date: April 19, 2017. to the meeting for the Committee’s inspected before being allowed on Time: 9:00 a.m. to 6:00 p.m. consideration. Any written comments campus. Visitors will be asked to show Agenda: To review and evaluate grant received after the 5:00 p.m. ET, April one form of identification (for example, applications. 14, 2017 deadline through April 18, a government-issued photo ID, driver’s Place: National Institutes of Health, 6701 2017 will be provided to the Committee license, or passport) and to state the Rockledge Drive, Bethesda, MD 20892 either before or after the meeting, (Virtual Meeting). purpose of their visit. Also as a part of Contact Person: Barna Dey, Ph.D., depending on the volume of comments security procedures, attendees should Scientific Review Officer, Center for received and the time required to be prepared to present a photo ID at the Scientific Review, National Institutes of process them in accordance with meeting registration desk during the Health, 6701 Rockledge Drive, Room 3184, privacy regulations and other applicable check-in process. Pre-registration is Bethesda, MD 20892, 301–451–2796, bdey@ Federal policies. All written public recommended. Seating will be limited mail.nih.gov. comments and oral public comment to the room capacity and seats will be Name of Committee: Center for Scientific statements received by the deadlines for on a first come, first served basis, with Review Special Emphasis Panel; Member both oral and written public comments expedited check-in for those who are Conflict: Clinical Oncology. will be provided to the IACC for their pre-registered. Date: April 25, 2017. consideration and will become part of Meeting schedule subject to change. Time: 1:00 p.m. to 3:00 p.m. the public record. Attachments of Information about the IACC is Agenda: To review and evaluate grant copyrighted publications are not applications. available on the Web site: http:// Place: National Institutes of Health, 6701 mstockstill on DSK3G9T082PROD with NOTICES permitted, but web links or citations for www.iacc.hhs.gov. Rockledge Drive, Bethesda, MD 20892 any copyrighted works cited may be Dated: March 28, 2017. (Telephone Conference Call). provided. Contact Person: Nicholas J. Donato, Ph.D., In the 2009 IACC Strategic Plan, the Melanie J. Pantoja, Scientific Review Officer, Center for IACC listed the ‘‘Spirit of Collaboration’’ Program Analyst, Office of Federal Advisory Scientific Review, National Institutes of as one of its core values, stating that, Committee Policy. Health, 6701 Rockledge Drive, Room 4040, ‘‘We will treat others with respect, listen [FR Doc. 2017–06407 Filed 3–31–17; 8:45 am] Bethesda, MD 20817, 301–827–4810, to diverse views with open minds, BILLING CODE 4140–01–P nick.donato@nih.gov. VerDate Sep<11>2014 18:32 Mar 31, 2017 Jkt 241001 PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 E:\FR\FM\03APN1.SGM 03APN1

Federal Register / Vol. 82, No. 62 / Monday, April 3, 2017 / Notices 16219 (Catalogue of Federal Domestic Assistance Workplace Drug Testing Programs Alere Toxicology Services, 450 Program Nos. 93.306, Comparative Medicine; (Mandatory Guidelines). The Mandatory Southlake Blvd., Richmond, VA 93.333, Clinical Research, 93.306, 93.333, Guidelines were first published in the 23236, 804–378–9130, (Formerly: 93.337, 93.393–93.396, 93.837–93.844, Federal Register on April 11, 1988 (53 Kroll Laboratory Specialists, Inc., 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) FR 11970), and subsequently revised in Scientific Testing Laboratories, Inc.; the Federal Register on June 9, 1994 (59 Kroll Scientific Testing Laboratories, Dated: March 28, 2017. FR 29908); September 30, 1997 (62 FR Inc.) Sylvia L. Neal, 51118); April 13, 2004 (69 FR 19644); Baptist Medical Center-Toxicology Program Analyst, Office of Federal Advisory November 25, 2008 (73 FR 71858); Laboratory, 11401 I–30, Little Rock, Committee Policy. December 10, 2008 (73 FR 75122); and AR 72209–7056, 501–202–2783, [FR Doc. 2017–06402 Filed 3–31–17; 8:45 am] on April 30, 2010 (75 FR 22809). (Formerly: Forensic Toxicology BILLING CODE 4140–01–P The Mandatory Guidelines were Laboratory Baptist Medical Center) initially developed in accordance with Clinical Reference Laboratory, Inc., 8433 Executive Order 12564 and section 503 Quivira Road, Lenexa, KS 66215– DEPARTMENT OF HEALTH AND of Public Law 100–71. The ‘‘Mandatory 2802, 800–445–6917 HUMAN SERVICES Guidelines for Federal Workplace Drug DrugScan, Inc., 200 Precision Road, Testing Programs,’’ as amended in the Suite 200, Horsham, PA 19044, 800– Substance Abuse and Mental Health revisions listed above, requires strict 235–4890 Services Administration standards that laboratories and IITFs Dynacare,* 245 Pall Mall Street, must meet in order to conduct drug and London, ONT, Canada N6A 1P4, 519– Current List of HHS-Certified 679–1630, (Formerly: Gamma- specimen validity tests on urine Laboratories and Instrumented Initial Dynacare Medical Laboratories) specimens for federal agencies. Testing Facilities Which Meet Minimum To become certified, an applicant ElSohly Laboratories, Inc., 5 Industrial Standards To Engage in Urine Drug laboratory or IITF must undergo three Park Drive, Oxford, MS 38655, 662– Testing for Federal Agencies rounds of performance testing plus an 236–2609 AGENCY: Substance Abuse and Mental on-site inspection. To maintain that Laboratory Corporation of America Health Services Administration, HHS. certification, a laboratory or IITF must Holdings, 7207 N. Gessner Road, participate in a quarterly performance Houston, TX 77040, 713–856–8288/ ACTION: Notice. testing program plus undergo periodic, 800–800–2387 SUMMARY: The Department of Health and on-site inspections. Laboratory Corporation of America Human Services (HHS) notifies federal Laboratories and IITFs in the Holdings, 69 First Ave., Raritan, NJ agencies of the laboratories and applicant stage of certification are not to 08869, 908–526–2400/800–437–4986, Instrumented Initial Testing Facilities be considered as meeting the minimum (Formerly: Roche Biomedical (IITF) currently certified to meet the requirements described in the HHS Laboratories, Inc.) standards of the Mandatory Guidelines Mandatory Guidelines. A HHS-certified Laboratory Corporation of America for Federal Workplace Drug Testing laboratory or IITF must have its letter of Holdings, 1904 Alexander Drive, Programs (Mandatory Guidelines). certification from HHS/SAMHSA Research Triangle Park, NC 27709, A notice listing all currently HHS- (formerly: HHS/NIDA), which attests 919–572–6900/800–833–3984, certified laboratories and IITFs is that it has met minimum standards. (Formerly: LabCorp Occupational published in the Federal Register In accordance with the Mandatory Testing Services, Inc., CompuChem during the first week of each month. If Guidelines dated November 25, 2008 Laboratories, Inc.; CompuChem any laboratory or IITF certification is (73 FR 71858), the following HHS- Laboratories, Inc., A Subsidiary of suspended or revoked, the laboratory or certified laboratories and IITFs meet the Roche Biomedical Laboratory; Roche IITF will be omitted from subsequent minimum standards to conduct drug CompuChem Laboratories, Inc., A lists until such time as it is restored to and specimen validity tests on urine Member of the Roche Group) full certification under the Mandatory specimens: Guidelines. * The Standards Council of Canada (SCC) voted HHS-Certified Instrumented Initial to end its Laboratory Accreditation Program for If any laboratory or IITF has Testing Facilities Substance Abuse (LAPSA) effective May 12, 1998. withdrawn from the HHS National Laboratories certified through that program were Laboratory Certification Program (NLCP) Dynacare, 6628 50th Street NW., accredited to conduct forensic urine drug testing as during the past month, it will be listed Edmonton, AB Canada T6B 2N7, 780– required by U.S. Department of Transportation 784–1190, (Formerly: Gamma- (DOT) regulations. As of that date, the certification at the end and will be omitted from the of those accredited Canadian laboratories will monthly listing thereafter. Dynacare Medical Laboratories) continue under DOT authority. The responsibility This notice is also available on the HHS-Certified Laboratories for conducting quarterly performance testing plus Internet at http://www.samhsa.gov/ periodic on-site inspections of those LAPSA- workplace. ACM Medical Laboratory, Inc., 160 accredited laboratories was transferred to the U.S. Elmgrove Park, Rochester, NY 14624, HHS, with the HHS’ NLCP contractor continuing to FOR FURTHER INFORMATION CONTACT: have an active role in the performance testing and 844–486–9226 laboratory inspection processes. Other Canadian Giselle Hersh, Division of Workplace Aegis Analytical Laboratories, Inc., 345 laboratories wishing to be considered for the NLCP Programs, SAMHSA/CSAP, 5600 Hill Ave., Nashville, TN 37210, 615– may apply directly to the NLCP contractor just as Fishers Lane, Room 16N03A, Rockville, 255–2400, (Formerly: Aegis Sciences U.S. laboratories do. Maryland 20857; 240–276–2600 (voice). Corporation, Aegis Analytical Upon finding a Canadian laboratory to be mstockstill on DSK3G9T082PROD with NOTICES qualified, HHS will recommend that DOT certify SUPPLEMENTARY INFORMATION: The Laboratories, Inc., Aegis Analytical the laboratory (Federal Register, July 16, 1996) as Department of Health and Human Laboratories) meeting the minimum standards of the Mandatory Services (HHS) notifies federal agencies Alere Toxicology Services, 1111 Newton Guidelines published in the Federal Register on of the laboratories and Instrumented St., Gretna, LA 70053, 504–361–8989/ November 25, 2008 (73 FR 71858). After receiving DOT certification, the laboratory will be included Initial Testing Facilities (IITF) currently 800–433–3823, (Formerly: Kroll in the monthly list of HHS-certified laboratories and certified to meet the standards of the Laboratory Specialists, Inc., participate in the NLCP certification maintenance Mandatory Guidelines for Federal Laboratory Specialists, Inc.) program. VerDate Sep<11>2014 18:32 Mar 31, 2017 Jkt 241001 PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 E:\FR\FM\03APN1.SGM 03APN1


Document Created: 2017-04-01 09:36:25
Document Modified: 2017-04-01 09:36:25
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesApril 14, 2017.
FR Citation82 FR 16218 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR